Reporting Under The Sunshine Act: Still In The Dark

Law360, New York (October 4, 2012, 1:51 PM EDT) -- With the U.S. Supreme Court’s decision to uphold almost all of the Patient Protection and Affordable Care Act, efforts are beginning in earnest to comply with the many aspects of federal health care reform law. 

As part of these efforts, the drug, biological, device and supply industry will need to devote substantial time and resources to comply with the physician payment and ownership transparency provisions — the Sunshine Act — for which data collection requirements could take effect as early as Jan. 1, 2013 (though at...
To view the full article, register now.